Factor V Leiden mutation in patients with inflammatory bowel disease [1]

Gastroenterology

Volumn 117, Issue 1, 1999, Pages 280-

  Spannagl, M ^a   Dick, A ^a   Folwaczny, C ^a   Schramm, W ^a   Loeschke, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

CONTROLLED STUDY; ENTERITIS; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; THROMBOEMBOLISM; ULCERATIVE COLITIS; VEIN THROMBOSIS;

EID: 0033034145     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70588-3     Document Type: Letter

References (5)

1. HA Liebman N Kashani D Sutherland The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease Gastroenterology 115 1998 830 834
2. FH Herrmann M Koesling W Schröder Prevalence of factor V Leiden mutation in various populations Genet Epidemiol 14 1997 403 411
3. SB Rosen A Sturk Activated protein C resistance—a major risk factor for thrombosis Eur J Clin Chem Clin Biochem 35 1997 501 516
4. W Schramm A Dick M Spannagl Bavarian study on clinical relevance of thromboembolic risk factors in women taking oral contraceptives Ann Haematol 74 1997 A108
5. LM Jackson PJ O'Gorman J O'Connell Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden QJM 90 1997 183 188